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ABSTRACT 
 
 
Diatoms have the ability to generate highly ornamented nanostructured silicified cell walls under ambient conditions and 
without harsh chemicals, yet the molecular mechanisms underlying biosilification are still not well understood.  The idea 
of this study is to mimic silica biomineralization of diatom cell walls that may provide the key to the development of 
new routes towards novel tailor-made silicas. Here the ability of R5 peptide, a peptide from the silaffin-1 protein derived 
from diatom species of Cylindrotheca fusiformis, to generate silica nanostructure in vitro was investigated.  The R5 
peptide was synthesized using Fmoc Solid-Phase Peptide Synthesis and purified using reverse phase high performance 
liquid chromatography.  MALDI analysis showed that the peptide was successfully synthesis.  With the application of 
silicic acid as a silica precursor and the peptide as catalyse, the formation of silica nanostructure was achieved.   AFM 
analysis of the precipitated silica from the mixture of silicic acid and the peptide revealed the nanostructure of silica 
spheres ranging between 50 – 300 nm in diameter.  Silica precipitate was not obtained in the absence of R5 (negative 
control) and when the silicic acid was mixed with poly-L-lysine (positive control), a network of large aggregates of 
uniform size of silica spheres of about 100 nm in diameter was observed. 
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1.  INTRODUCTION 
 
Silicon based-materials have become increasingly important in many industrial applications resulting in increased in 
demand for well defined material formulations.1  However, the fabrication of chemically synthesized silicon based 
materials generally requires harsh reaction conditions, high pressure and high temperature and is not environmentally 
friendly since the industrial processes generate extensive caustic chemical waste.2 
 
Recently, there has been a great deal of interest focusing on the design and manufacture of devices at nanoscale in which 
current commercial micro and meso-fabrication methods have largely been based on two-dimensional processing 
principles which are not well suited to the low-cost mass production of three-dimensional micro devices.3  An alternative 
approach to the manufacture of nanostructure materials is to learn from nature: a natural source of varying silica 
nanostructure can for example be found in the unicellular microscopic algae known as diatoms.4   
 
The ability of diatoms to generate highly ornamented three-dimensional nanostructured silicified cell walls at ambient 
conditions and without harsh chemical has inspired scientists in the design and manufacture of nanostructure materials 
for many industrial applications. However, the exact mechanisms of biosilification are still not well understood.5  The 
understanding of biomolecular and physico-chemical processes that steer biosilica formation is important for the design 
of process technological innovations and for the production of industrial silica under mild reaction conditions, 
environmentally friendly and more economically.6 Hence, mimicking silica biomineralization of diatoms may provide 
the key to the development of new routes towards novel tailor-made silicas.   
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Silaffin-1 (Sil1) is a protein from Cylindrotheca fusiformis that consists of seven highly homologous repeating units, R1 
to R77and the R5, a short 19 amino acid sequence, H2N-SSKKSGSYSGSKGSKRRIL-COOH has been shown to 
catalyse the formation of silica nanospheres within minutes when added to silicic acid at neutral pH and under ambient 
temperature in vitro.8  Therefore, the aim of this study is to investigate the formation of silica nanostructures from a silica 
precursor catalyzed by R5 peptide. 
 
 
 
2.  MATERIALS AND METHODS 
 
2.1  Synthesis of the R5 peptide 
  
Solid Phase Peptide Synthesis (SPPS).  R5 peptide was synthesized using Solid Phase Peptide Synthesis.  Prior to 
coupling, the amount of the reagents (HOBt, HBTU and DIEA) and excess of amino acids used in the synthesis was 
determined.  100 mg of Fmoc-L-Leu-wang resin was weighted and added to the glass vessel.  The resin was swelled with 
10 ml dichloromethane (DCM) with shaking for about an hour.  The DCM was drained by attaching vacuum to the 
bottom of the vessel and turn water on.  After draining the DCM, a 10 ml of N,N-dimethyl formamide (DMF) was then 
added to the resin and swelled for another 3 hours.  The DMF was drained and the Fmoc group on the resin bound amino 
acid was removed with 5 ml of 25% piperidine in DMF by shaking for 10 minutes. Deprotection with 25% piperidine in 
DMF was repeated twice. It was then rinsed with 10 ml of DMF for 5 minutes (4 times).  Following this, the next 
protected amino acid was added.  3 times excess of the mass of the next amino acid, 3 times excess of HOBt and 3 times 
excess of HBTU were weighted and placed in a tube.  5 ml of DMF was added to the tube and mixed using vortex.  The 
mixture was then added to the reaction vessel.  9 times excess of the DIEA was added to the mixture and then shaken for 
about 2 hours.  After 2 hours coupling, the resin was drained and washed with 5 ml DMF for 5 minutes repeated 3 times.   
Kaiser Test.  To test whether coupling occurred, the Kaiser test was performed by placing a few beads in a small vial 
and adding a few drops of all three Kaiser Test solutions.  The vial was then placed in a beaker of heated water for about 
2 minutes.  The colour change of the beads was observed.  If the beads turn black, the coupling had failed and recoupling 
or capping had to be performed.   
Cleavage the peptide.  After the completion of the peptide assembly, the peptide was cleaved from the resin.  Prior to 
cleavage, the Fmoc group of the last amino acid to be coupled was removed with 5 ml of piperidine and shaken for 15 
minutes (2 times).  The resin was then washed three times with 5 ml DMF for 5 minutes, three times with 5 ml DCM for 
5 minutes, three times with 5 ml methanol for 5 minutes and three times with 5 ml diethyether for 5 minutes.  Following 
this, the resin was drained and the beads were dried overnight in a dessicator with dessicant.   
Cleavage the peptide was accomplished using a cleavage mixture containing 9.0 ml of trifluoroacetic acid (TFA), 0.5 ml 
of thioanisole, 0.3 ml of 1,2-ethanedithiol (EDT) and 0.2 ml of anisole.  Nitrogen was bubbled through the cleavage 
mixture and then added to the vessel.  The peptide on the resin was allowed to react with the cleavage mixture for several 
hours (2-4 hours) with shaking.   The samples were drained into a tube and aliquated them into six 1.5 ml eppendorf 
tubes.   The tubes were placed in centrivap concentrator LABCONCO and spun for 15 minutes or until the volume was 1 
ml or less.  The spun down solutions were added drop wise into the cold diethyl ether.  A precipitate formed and the 
sample was then incubated in the fridge overnight.   
The precipitated solution was aliquoted in two 50 ml centrifuge tubes (equal volume) and centrifuged at 3000 rpm and 
4oC for 15 minutes.  The supernatant was removed and fresh cold diethyl ether was added followed by another 
centrifugation.  Additional cold diethyl ether and centrifugation were repeated 3 times.  After the last centrifugation, the 
supernatant was removed until below 5 ml and placed in four Eppendorf tubes.  Again, the samples were centrifuged at 
13000 rpm for 30 seconds.  The supernatant was discarded and 1 ml of glacial acetic acid was added to the tubes.  The 
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samples were sonicated for 20 minutes and placed in cold vacuum to remove the solvent.    The dried peptide was stored 
in the freezer for further analysis. 
2.2  Purification of the Synthetic R5 peptide using Reverse Phase High Performance Liquid Chromatography 
(RP-HPLC) 
 
The crude peptide was purified using RP-HPLC (The Hitachi D-7000). The column used for separation of the 
components of the synthetic peptide was C8 (VYDAC 208TP510).  Two solvents were used, solvent A and B.  The A 
and B are commonly used to refer to the aqueous and organic solvent respectively.  The solvent A contain 10 ml of 
HPLC grade acetonitrile, milliQ water (make up to 1 litre) and before adding 1 ml Trifluoroacetic acid (TFA), the 
solvent was degassed for about 1 hour to remove air bubble.  The solvent B contains 50 ml of milliQ water and was 
made up to 500 ml with HPLC grade acetonitrile.  The solvent was degassed for 1 h before adding 0.35 ml TFA. 
 
The sample was dissolved in 1 ml solvent A. The samples were separated by reverse phase HPLC on a C8 column by 
application of 5 – 40% of solvent B in 30 minutes. The fraction from each peak was collected.  Each of the fractions 
from the crude peptide was analyzed with MALDI-MS and the fractions of selected peaks were then lyophilized and 
stored frozen at -20oC for further analysis. 
 
 
2.3  Maldi-MS (Matrix Assisted Laser Desorption Ionization Mass Spectrometry) 
 
The matrix used for the synthetic R5 peptide was α-cyano-4-hydroxycinnamic acid (CNCA).   The matrix solution was 
prepared by dissolving 10 mg of CNCA in a mixture of 495 µl of acetonitrile, 495 µl of ethanol, 10 µl of 0.1% aqueous 
trifluoroacetic acid (TFA).  The solution was vortexed and then centrifuged for 30 seconds at 7000 rpm.  Only the 
supernatant was used for the preparation of the samples.  Following this, 20 µl of the matrix solution was mixed with 20 
µl of the peptide fraction from the HPLC. 
 
 
 
2.4  Silica precipitation assay 
 
Silica precipitation assay was performed according to the method of Naik et al. (2003).  Silicic acid solution was 
prepared by hydrolyzing 1 M TMOS (tetramethyl orthosilicate) with 1 mM HCl for about 30 minutes with agitation.  
Silicic acid solution was then mixed with  the peptide stock at a concentration of 100 mg/ml milliQ water.  The mixture 
was incubated for 15 minutes at room temperature.  After incubation, the mixture was centrifuged for 3 minutes at 14000 
rpm.  The supernatant was carefully removed and the precipitated silica was washed three times with milliQ water.   
Similarly, poly-L-lysine was mixed with silicic acid solution at a concentration of 100 mg/ml and incubated for 15 
minutes at room temperature followed by centrifugation.  The precipitated silica was then washed 3 times with milliQ 
water by repetitive centrifugation and resuspension. 
 
 
2.5  Atomic Force Microscopy (AFM)  
 
The precipitated silica was mounted onto the silicon wafer and air dried.  The silicon wafers were then adhered to metal 
pucks with double-sided adhesive.  The cleaned silicon wafer without sample, the silicic acid solution incubated without 
the peptide and the poly-L-lysine were prepared as controls.  For tapping mode AFM experiments, Olympus tapping 
mode etched silicon probes (Digital Instruments/Veeco Meteorology Group, Santa Barbara, California) with a resonancy 
frequency range of 100-500 kHz were used.  All images and force measurements were acquired using a Nanoscope IV 
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Multimode SPM (Digital Instruments/Veeco Meteorology Group, Santa Barbara, Calif ornia).  The target amplitude used 
ranged between 2 and 3 V.  The amplitude set point was always maximized to reduce the force exerted by the tip on the 
sample (a typical value is 2.0 V).  The height and the ampl itude channels were monitored in most experiments.  The 
scanning parameters were almost always set to optimize the height image quality.  Gains were typically integral gains of 
about 0.1 and proportional gain of about 1.0.  The scan rate was less than 2 Hz. 
 
2.6   Scanning Electron Microscopy (SEM)  
 
The procedure for preparation of SEM sample is similar to that for AFM with additional procedure for SEM is that the 
samples were coated with either gold or platinum prior to SEM investigation.  All images were obtained using Philips 
XL30 Field Emission Scanning Electron Microscope.  
 
 
3.  RESULTS AND DISCUSSION 
 
 
3.1  Synthesize, purification and char acterization of the R5 peptide 
 
In the present study, the R5 peptide was successfully synthesised using the Fmoc solid phase peptide synthesis.  The 
crude synthetic peptides were purified by reverse phase HPLC  on a C8 column with the application of 5-40% of solvent 
B in 30 minutes.  The elution of the peptides was monitored using the absorbance at 210 nm.   
 
HPLC analysis of the crude peptide show ed some peaks indicating the presence of some side products (Figure 1).  As 
can be seen from the graph, there were three major peaks el uted from the sample. To confirm that the desired peptides 
were successfully synthesized, aliquots of peak fractions were subjected to matr ix assisted laser desorption ionization 
mass spectrometry (MALDI-MS).   As ex pected, MALDI-MS analysis confirmed that the main fraction eluted in 
minutes 16-19 did indeed contained the expected peptide sequence (H2N-SSKKSGSYSGSKGSKRRIL-COOH) with a 
mass/charge ration of 2014.21 m/z  (Figure 2).  The main fractions after successive run were pooled and concentrated by 
lyophilization.   
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1. Reverse phase HPLC profile of the crude peptide.  200 µl of the sample was applied to the column under the buffer and 
gradient   conditions described.  The flow rate was 2. 5 ml/min and the run was monitored at 210 nm.  
Pooled Fractions
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 Figure 2. MALDI-MS analysis of the fraction from reversed phase HPLC that contain the R5 peptide 
 
 
Although the spectrum of the purified peptide contained some other minor peaks, the major peak corresponded to the 
expected product was still the majority of the end product.  It was due to the nature of chemical synthesis that the crude 
peptide obtained from this study contained many side-products which are a result of incomplete coupling of the next 
amino acid or truncated peptides as well as side reacti ons that may occur during the cleavage, deprotection and 
purification.  In addition, not all of these side products could be separated by HPLC. At the end of the purification 
process, the final recovery of the peptide was about 5 mg which was enough for the purposes of this study.   
 
Every peptide sequence synthesized is unique and some peptid es sequences are difficult to  synthesize. A Successful of 
the peptide synthesis can be attributed to many factors. One of the factors was the nature of  the peptide in terms of the 
length and amino acid sequences. Repetitive amino acid sequences like for example oligo- proline, -lysine or -arginine 
give rise to difficult coupling steps. This was true for R5 peptides which contain repetitive lysine, serine and arginine 
residues.  During the synthesis, assembly of these amino acids into the growing peptide was quite difficult and capping 
procedures had to be performed due to the negative result of the Ka iser Test indicating the incompleteness of coupling.        
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3.2  Silica Nanostructure Formation From R5 Peptide 
 
In the present study, a biomimetic study of silica nanostructure formation is presented.  Two catalysts, the synthetic R5 
peptide and a synthetic polyamine, poly-L-lysine were used in the presence of silicic acid.  The silicic acid was 
synthesizes by dissolving 1 M TMOS in 1 mM HCl.  This product was then mixed with one of the catalyst (as described 
in materials and methods).  A control without the peptide was also treated with silicic acid solution. 
 
In agreemenet with previous studies, the formation of silica nanoparticles was observed in the presence of both the R5 
peptide and poly-L-lysine, respectively.  The morphologies of the precipitated silica were investigated by scanning 
electron microscopy (SEM) and atomic force microscopy (AFM) techniques.  
 
Tapping mode AFM analysis revealed the formation of nanostructure of spherical particles synthesized using the peptide.  
Interestingly, the nanoparticle size formed by the mixture of the synthetic R5 peptide and the silicic acid solution was not 
uniform in size.   The cross section analysis of the sample in Figure 4A revealed the size of the particles were about 50-
300 nm in diameter. This is somewhat smaller than the 400–600 nm diameter particles observed by Naik et al 9.   
 
A possible explanation for the variation in size diameter was that the peptides used contain some side products including 
truncated peptides that might also react with the silicic acid.  A study done by Knecht and Wright 10 reported a synthetic 
site-directed mutagenesis study of the full length non-post-translationally modified R5 peptide.  The results of this study 
showed that the R5 peptide formed a network of spherical silica nanoparticles 250-450 nm in diameter, whereas R5 
truncates resulted in the formation of smaller particles ranging from 60-400 nm. 
                                                                                                                                                              
Even more interesting was that in the presence of poly-L-lysine, a heavily fused mass of uniform size of silica spheres 
approximately 100 nm in size was achieved, as evident in Figure 5.   This result is in agreement with previous studies.  
The average particle sizes of silica particles formed was about 108 nm in diameter11 and Mizutani et al12 also have 
demonstrated the ability of poly-L-lysine to precipitate silica consisting of agglomerated nanoparticles of 50-100 nm in 
diameter.   
 
 In contrast, in the absence of the peptide, no silica nanospheres formation was observed.   Cross-section analysis of the 
control as evident in Figure 3A showed a flat surface. 
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Figure 3.  Tapping mode AFM images of the control containing silic ic acid without the peptide (3A). Two dimensional structure a nd 
section analysis of the control.  (3B). Th ree dimensional structure of the control. 
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Figure 4.  Tapping mode AFM images of prec ipitated silica formed by the mixture of the R5 peptide and silicic acid solution at 
concentration of 100 mg/ml  (4A).   Two dimensional structur e of the precipitated silica and its section analysis.  (4B) 
Three dimensional structure the precipitated silica . 
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Figure 5.  A series of SEM images of precipitated silica formed by the mixture of poly-L-lysine and silicic acid solution at a 
concentration of 100 mg/ml 
 
 
As can be seen clearly from Figure 5, a large aggregate of heavily fused mass of  uniform size of silica spheres of about 
100 nm in diameter was produced in the presence of poly-L-lysine.   
 
Compared to the previous st udy examining the use of poly (amino acids) such  as poly-L-lysine to precipitate silica, 
spherical nanostructures were achieved if anions like phosphat e were added to the solution and the particle diameters of 
silica nanostructure were varied ranging between 200-400 nm 13 .  In this study, poly-L-lysine was capable of precipitating 
silica in the absence of anions like phosphate.  Furthermore, the size of the resulting precipitated silica was uniform of 
about 100 nm in diameter.   
 
In contrast to the previous studies that utilized anions like phosphate as a buffer when studying silica formation by poly-
L-lysine,   the present study did not use any buffer, only th e mixture of the poly-L-lysine and the silicic acid solution in 
water. The reason for that was because we wanted to co mpare this reaction with the silica precipitation by the R5 
peptide.     
 
 
 
  
5.  CONCLUSIONS 
 
We have demonstrated that the R5 pep tide was successfully synthesis using Fmoc solid phase peptide synthesis, purified 
by reverse phase HPLC and confirmed the peptide sequence by MA LDI-TOF mass spectrometry.   Exposure of this 
peptide to the silicic acid solution resulted in the forma tion of silica nanostructures ranging from 50 – 300 nm in 
diameter.  We also report here the formation of well-defi ned silica spheres facilitated by the synthetic polyamine (poly-
L-lysine) using tetramethoxysilane as a silica precursor.  A la rge aggregate of heavily fused silica nanoparticle of about 
100 nm in diameter was observed.  In contrast, in the absence of the either the peptide or the synthetic polyamine, no 
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silica nanostructure was observed.  The results of this project could be useful for the development of new routes towards 
the environmentally benign synthesis and patterning of well defined silicon based material at low cost.  
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